Vaccines
Vaccine trials demand agility to adapt to changing study environments—from shifting disease hotspots to evolving diversity requirements. The right clinical site network is critical to manage these large, complex trials, handle volume spikes and keep studies on schedule.
Why Trialmed for vaccine clinical trials?
We understand the burden of finding, engaging and recruiting the right volunteers into vaccine studies. Our 40 years of experience profiling populations to identify potential patients and randomizing them into studies gives us key insights into pre-pooling volunteers prior to start-up and managing surge capacity.
We offer a global clinical site network of ready-to-deploy, vaccine-enabled sites purpose-built for large volume studies and delivering global, consistent operations —with investigators experienced in managing vaccine studies. We’ve successfully supported vaccine protocols for a range of infectious diseases, such as influenza and RSV, and emerging diseases like COVID-19, Ebola, avian influenza, Anthrax, and Zika.
Other key Trialmed differentiators include:
Centralized recruiting platform
Geo-targeted platform that finds and recruits the right volunteer populations on a massive scale
Proprietary database
More than 6.8M potential patients for recruitment
Experience
Demographic targeted methodologies that result in high volunteer retention rates.
Trialmed experience.
370+ vaccine trials supported from first-in-human to Phase I-III
48,000+ randomized volunteers in 30 major vaccine areas